Lansoprazole

Drug Profile

Lansoprazole

Alternative Names: A-65006; AG-1749; Agopton; Bamalite; Estomil; Ilsatec; Lampion; Lansap; Lansone; Lansox; Lanzo; Lanzor; Limpidex; Ogast; Ogastro; Opiren; Prevacid; Prevacid 24HR; Prezal; Pro-Ulco; Takepron; Takepron Capsules 15; Takepron OD Tablets 15; TakepronIV; Zoton

Latest Information Update: 25 Mar 2017

Price : $50

At a glance

  • Originator Takeda
  • Class Antiulcers; Benzimidazoles; Gastric antisecretories; Pyridines; Small molecules; Sulfoxides
  • Mechanism of Action Proton pump inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Duodenal ulcer; Dyspepsia; Gastric ulcer; Gastro-oesophageal reflux; Heartburn; Helicobacter infections; NSAID-induced ulcer; Peptic ulcer; Zollinger-Ellison syndrome
  • No development reported Gastritis
  • Discontinued Bleeding ulcer

Most Recent Events

  • 08 Mar 2016 Biomarkers information updated
  • 21 Feb 2013 Registered for Gastritis (in combination with amoxicillin and clarithromycin or metronidazole as triple therapy for Helicobacter pylori gastritis) in Japan (PO)
  • 02 Jan 2013 Abbott separates its pharmaceuticals business to new company called AbbVie
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top